KB-295

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameKB-295
Drug Alias Namemicrobiome metabolic therapeutic (Kaleido)KB-295
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMicrobiome modulators
TargetsUpdating
Therapy Area/IndicationsInflammatory Bowel DiseasesColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIreland
CombinationsNo
Global Highest StatusDiscontinued (Clinical)
Highest Status in ChinaN/A
Originator CompaniesKaleido Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKaleido Biosciences Inc
Active IndicationsN/A
Inactive IndicationsInflammatory Bowel DiseasesColitis, Ulcerative

Other Information

ATC CodeN/A
Related LinksN/A